For instance, expression of MYOD1 can predict patient survival in lung cancer patients (Jiang et al., 2015) and high expression of MEF2C is associated with poor outcome in acute myeloid leukemia (AML) patients (Laszlo et al., 2015). This evidence concerns the gene MEF2C and lung cancer.